Expertise that connects science, policy and access

From early development to market access and beyond, we deliver integrated advice and evidence driven solutions that help innovative medicines and vaccines achieve sustainable access and better health outcomes.

Learn More About Us Contact Us

Who We Are

A unique fusion of public health leadership and market access expertise.

Stuart Carroll
senior health economist and epidemiologist

Over 22 years of experience in infectious diseases, vaccines, market access and health policy.

✓ Former Director of Market Access & Policy Affairs, Moderna UK & Ireland
✓ Former Senior Expert Adviser, UK Government
✓ Author of 180+ peer reviewed papers

View Full Bio

Professor Sir Jonathan Van-Tam
Physicial & Public Health Expert

Internationally recognised leader in public health, respiratory viruses and pandemic response.

✓ Former Deputy Chief Medical Officer for England (2017-2022)
✓ Knighted in 2022 for services to public health
✓ Extensive academic and government experience

View Full Bio

About CVT

CVT Market Access Solutions Ltd creates a fusion of Stuart Carroll’s two decades of experience across vaccines, infectious diseases, market access and public health policy, with Jonathan Van-Tam’s lifetime of medical and public health policy expertise. This creates a unique offering for clients, especially pharmaceutical companies seeking to navigate complex healthcare ecosystems and policy landscapes to secure sustainable access for innovative medicines and vaccines. The firm combines expertise in market access strategy, health economics and outcomes research (HEOR), pricing and reimbursement, medical affairs, and government policy with deep experience in public health and health technology assessment.

CVT advisors work at the intersection of science, medicine, policy and healthcare systems, to provide strategic support and advice across the full product lifecycle, from early evidence generation and access strategy through to policy engagement, reimbursement negotiations and stakeholder communications.

Market Access and 
Strategy 

HEOR & Evidence Generation

Pricing & 
Reimbursement

Medical Affairs & 
Policy

Government & 
Health Policy

Medical Affairs & Scientific Strategy

How We Operate

01 |  Advisory firm, not agency

We are an advisory firm not an agency; our support to you comes in the form of written and spoken advice, alongside detailed review of your company’s propositions and strategies, as required.

02 |  Not a delivery partner

We are not a delivery partner who provides services, as agencies typically do.

03 |  Work alongside clients

We work alongside clients and inside their organisations, but we don’t ‘front’ outsourced activities on behalf of clients.

04 |  No junior staff delegation

We are currently a ‘two-person band’: we have no junior staff to whom we can delegate.

05 |  Direct access to the founders

Our clients get direct access to the two named experts who are the co-owners and founders of CVT.

06 |  Flexible work effort

Our clients ultimately choose the weighting of the ‘work effort’ they wish to receive from the two CVT advisors.

07 |  Selective assignments

We only accept assignments where we feel satisfied that: a) we can make a meaningful contribution; and b) the sum of our combined contributions is likely to be greater than its constituent separate parts

08 |  Honest, realistic advice

We are not ‘yes people’; we will always give honest and realistic advice to our clients, even when we think it may be hard to hear.

09 | Reputation and client satisfaction

We realise we are only as good as our current or recent reputation and obsess about feedback and client satisfaction.

Where We Can Help

Market Access Strategy

  • Global and UK market access strategy development
  • Early access and lifecycle planning
  • Stakeholder mapping and payer insight

Health Economics & Outcomes Research

  • Assessing and designing Health Economics & Outcomes Research (HEOR)
  • Assessing and designing cost-effectiveness modelling and economic evaluation
  • Assessing and designing burden of disease and epidemiological modelling
  • Assessing and shaping Value dossiers and evidence synthesis
  • Evidence generation strategy for HTA submissions

Pricing & Reimbursement

  • Pricing strategy and value positioning
  • Support for reimbursement submissions and negotiations
  • Health technology assessment strategy and engagement with agencies such as National Institute for Health and Care Excellence
  • Scenario modelling for payer decision-making

Vaccine Policy & Pandemic Preparedness

  • Vaccine policy strategy
  • Pandemic preparedness planning and response strategy
  • Policy engagement with advisory bodies including the Joint Committee on Vaccination and Immunisation

Government & Health Policy

  • Policy analysis and strategic advisory
  • Public affairs and government engagement
  • Parliamentary and policy landscape monitoring
  • Strategic positioning in evolving health policy environments

Medical Affairs & Scientific Strategy

  • Scientific engagement strategy
  • Advisory board and expert network development
  • Medical education and scientific communication
  • Evidence translation for policy and clinical stakeholders

Strategic Communications

  • Public health communications strategy
  • Scientific messaging and narrative development
  • Media and stakeholder engagement strategy
  • Crisis and risk communication

Get In Touch

We would love to hear from you.
Please fill out the form and we will be in contact.

All fields are ​mandatory.

Send Message
Thank you! Your message has been sent.
Unable to send your message. Please fix errors then try again.